wire - news in brief


Category



Results 101 - 150 of 392.


Innovation - Computer Science / Telecom - 03.12.2019

Pharmacology - Health - 02.12.2019
Novartis breadth of data at 2019 ASH demonstrates commitment to reimagining medicine in hematology through innovative therapeutic platforms
Patients & Caregivers Healthcare Professionals Society & ESG With more than 140 abstracts, Novartis continues its leadership in hematology innovation   Data for MBG453, an innovative anti-TIM

Health - Pharmacology - 02.12.2019

Social Sciences - 02.12.2019
"100 women and 1000 more": Sara Greco
Causal Effects of Brevity on Style and Success in Social Media Faculty of Informatics Open lecture of the course Argumentation in Conflict Resolution Visiting Alumni: Loredana Padurean, Associate Dean, Asia School of Business «Quel ramo del lago di Como...».

Health - Pharmacology - 02.12.2019
Improving Tuberculosis Screening in Remote Areas
Improving Tuberculosis Screening in Remote Areas
Every year, 1.5 million people die from tuberculosis (TB) worldwide. Diagnosis and treatment is particularly difficult in remote rural areas.

Pharmacology - Health - 02.12.2019
Positive phase III results for Roche’s satralizumab in neuromyelitis optica spectrum disorder published in the New England Journal of Medicine
Satralizumab demonstrated robust efficacy, sustained for 144 weeks, in significantly reducing the risk of relapse in combination with baseline immunosuppressant therapy Satralizumab targets the interleukin-6 (IL-6) receptor, a potential key driver of neuromyelitis optica spectrum disorder (NMOSD) NMOSD is a rare, debilitating autoimmune disease of the central nervous system that can cause visual impairment, motor disability and even death Roche

Business / Economics - Innovation - 02.12.2019

Astronomy / Space Science - Politics - 28.11.2019
ESA Ministerial Council Meeting: Switzerland to participate in new programmes and play a leading role in the removal of space debris
On 27 and 28 November 2019, State Secretary Martina Hirayama attended the European Space Agency's ESA Ministerial Council meeting in Seville ("Space 19+").

Innovation - Business / Economics - 28.11.2019
How smartphones can verify your identity
How smartphones can verify your identity
Anyone who wants to open a bank account or buy a mobile phone plan has to identify themselves to the respective service provider.

Astronomy / Space Science - Event - 26.11.2019

Astronomy / Space Science - Microtechnics - 26.11.2019
An EPFL robot in space
An EPFL robot in space
The crew of the International Space Station has taken delivery of a haptic interface designed by EPFL spin-off Force Dimension. Astronauts could one day use the device, based on the famous delta robot developed at EPFL by Reymond Clavel, to control unmanned Martian and lunar rovers from afar. In a project called METERON, the European Space Agency (ESA) is exploring how advanced robots could be used to repair satellites in orbit or probe hostile environments like the Martian and lunar surfaces.

Environment - 25.11.2019
Measuring station in Davos officially labelled
Measuring station in Davos officially labelled
Greenhouse gases are the cause of climate change. The European infrastructure network ICOS (Integrated Carbon Observation System) is committed to standardised measurements so that emissions can be compared across Europe.

Astronomy / Space Science - 25.11.2019
Media conference "Launch of the CHEOPS mission"
For the time being, the Swiss space telescope CHEOPS is scheduled to begin its journey into space in mid-December on board a Soyuz rocket from the European Space Agency (ESA) in Kourou, French Guiana.

Pharmacology - Health - 25.11.2019
FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy
Filing submission includes 12-month data from pivotal FIREFISH and SUNFISH trials in a broad population of people living with Types 1, 2 or 3 SMA Roche today announced that the U.S. Foo

Mathematics - Physics - 25.11.2019
The random importance of clouds
The random importance of clouds
Juhan Aru is a new professor in Mathematics at EPFL where he holds the Chair of Random Geometry. His work aims at understanding geometric properties of models where randomness and geometry meet.

Health - Pharmacology - 22.11.2019
Roche presents pivotal data demonstrating Tecentriq in combination with Avastin improves overall survival in people with the most common form of liver cancer
First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival in people with unresectable hepatocellular carcinoma compared with sorafenib Result

Event - History / Archeology - 21.11.2019

Academic Rankings - Materials Science - 20.11.2019

Chemistry - Physics - 20.11.2019
A chemist and her children
A chemist and her children
This year Renana Gershoni-Poranne was awarded a Branco Weiss Fellowship. The ETH chemist will use the research grant to design innovative compounds that can be used in future generations of electronic devices.

Materials Science - 19.11.2019
With artificial intelligence to a better wood product
With artificial intelligence to a better wood product
Empa scientist Mark Schubert and his team would like to use the many opportunities offered by machine learning for wood technology applications. Together with Swiss Wood Solutions, Schubert will present his latest project at the Swiss Innovation Forum on 21 November in Basel. Wood is a natural material that is lightweight and sustainable, with excellent physical properties, which make it an excellent choice for constructing a wide range of products with high quality requirements - for example for musical instruments and sports equipment.

Innovation - 19.11.2019
EPFL hosts a new SBB innovation unit
Swiss Federal Railways (SBB) opened a new innovation unit today at EPFL's Innovation Park, further deepening its ties with the School.

Environment - 19.11.2019

Pharmacology - Health - 18.11.2019
Roche to present new and updated data for seven approved and investigational medicines across multiple types of breast cancer at the 2019 San Antonio Breast Cancer Symposium
Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer Follow-up data from pivotal phase III APHINITY study evaluating Perjeta plus Hercepti

Astronomy / Space Science - Computer Science / Telecom - 18.11.2019
Katie Bouman, the scientist who reveals the invisible
Katie Bouman, the scientist who reveals the invisible
The first-ever image of a black hole was unveiled to the public this past April. It was produced by a team of 200 scientists as part of the Event Horizon Telescope Project.

Pharmacology - Health - 17.11.2019
Novartis PARAGON-HF analyses suggest Entresto benefit beyond HFrEF
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare

Event - Physics - 16.11.2019

Pharmacology - Health - 15.11.2019
New Novartis medicine Adakveo (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1   Adakveo reduced the an

Pharmacology - Health - 15.11.2019
Novartis receives positive CHMP opinion for Mayzent (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS)
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda

Pharmacology - Health - 15.11.2019
CHMP recommends conditional EU approval of Roche’s Polivy for people with previously treated aggressive lymphoma
First-in-class antibody-drug conjugate that specifically targets CD79b, a protein expressed in the majority of B-cells Targeted off-the-shelf treatment represents potential new option for people with

Pharmacology - Health - 15.11.2019
CHMP recommends EU approval of Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment
Kadcyla cut the risk of disease recurrence or death by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer At three years, 88.3% of

Event - Life Sciences - 15.11.2019

Environment - 14.11.2019
EPFL-developed geothermal panels reach international finals
EPFL-developed geothermal panels reach international finals
EPFL researchers have developed a geothermal system for recovering the heat captured in basements, subway tunnels and underground parking garages.

Mathematics - 13.11.2019

Health - Life Sciences - 13.11.2019
Award for project on Heart Transplantation
Award for project on Heart Transplantation
This year's Johanna Dürmüller-Bol DBMR Research Award of the Department for BioMedical Research (DBMR) of the University of Bern goes to Maria-Nieves Sanz.

Environment - 13.11.2019
A more sustainable material to reinforce concrete structures
A more sustainable material to reinforce concrete structures
The next generation of ultra high-performance fiber-reinforced concrete (UHPFRC) has just been created at EPFL. The new material will be used to strengthen bridges and other structures - both new and old. What's more, the process of manufacturing this material releases 60-70% less CO2 than the previous generation of fiber-reinforced concrete.

Pharmacology - Health - 12.11.2019
New Novartis PREVENT data show Cosentyx delivers early relief in axial spondyloarthritis
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores